S&P 500 jumps as AMD rally leads tech higher
NEW YORK - Q/C Technologies, Inc., formerly known as TNF Pharmaceuticals, Inc., began trading under its new ticker symbol "QCLS" on Nasdaq Thursday, the company announced in a press release. According to InvestingPro data, the stock has shown significant returns over the past week, though it typically trades with high volatility.
The name and ticker change reflect the company’s strategic shift from pharmaceuticals to quantum-class computing technology. Q/C Technologies now holds exclusive global rights to LightSolver’s laser processing unit (LPU) technology for applications in cryptocurrency verticals. The company maintains a strong financial position with more cash than debt on its balance sheet, though InvestingPro analysis reveals 10+ additional key insights about the company’s financial health.
"The official transition to Q/C Technologies and our new Nasdaq ticker is an important milestone in aligning our public identity with the Company’s transformation," said Joshua Silverman, Executive Chairman of Q/C Technologies.
The company described its new focus as developing "energy-efficient quantum class, high-performance computing infrastructure" through its licensing agreement with LightSolver. The agreement grants Q/C exclusive rights to use laser-based processing units that the company claims can solve compute-intensive problems "at the speed of light."
No action is required from current shareholders regarding the name and ticker symbol change, and the company’s CUSIP number remains unchanged.
Q/C Technologies was previously listed on Nasdaq under the ticker symbol "TNFA" when it operated as TNF Pharmaceuticals, Inc.
In other recent news, TNF Pharmaceuticals has announced a significant strategic shift by pivoting from pharmaceuticals to quantum-class computing. This move includes rebranding as Q/C Technologies and trading under the new ticker symbol QCLS on the Nasdaq Capital Market, effective September 25, 2025. As part of this transformation, the company has secured exclusive global rights to LightSolver’s light-speed laser processing unit technology, aimed at enhancing cryptocurrency applications. This licensing agreement positions Q/C Technologies to leverage cutting-edge technology for faster computational processing. Additionally, TNF Pharmaceuticals has successfully regained compliance with Nasdaq’s minimum bid price requirement, maintaining a minimum bid price of $1.00 for 10 consecutive business days. The company also raised $7 million through a private placement of convertible preferred stock, led by its largest strategic stockholder. These recent developments mark a significant transition for the company as it ventures into the field of quantum computing.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.